BOLD vs DVA · P/E 0.1, $24.6M cap vs P/E 14, rev $12.82B
Boundless Bio, Inc. Common Stock (BOLD) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the BOLD and DVA stock pages for the full models.
Not investment advice.